A cold vapor atomic absorption technique for blood or urine mercury analysis that uses persulfate oxidation to prepare samples for total mercury analysis and acid permanganate oxidation to prepare samples for inorganic mercury analysis is described. The linearity of the procedures ranged from 0.5 to 25 pg/l. Precision ranged from 20% at 1 pg/L to 7% at 20 pg/L. Documentation of accuracy is based on analysis of samples prepared by an international proficiency survey program. The development of a two-step digestion procedure followed by automated flowinjection mercury analysis was a necessary precursor to the assessment of inorganic and alkylmercury exposure in a large unexposed human population. Application of this technique to 902 blood and 902 urine samples collected from a normal human population who had no extraordinary mercury exposure generated mean plus two standard deviation skewed confidence-limit ranges of results as follows: blood total mercury, 0-8.4 pg/L; blood inorganic mercury, 0-1.7 pg/L; blood organic mercury, 0-7.5 pg/L; urine total mercury, 0-9.9 pg/L; urine inorganic mercury, 0-8.6 pg/L; and urine organic mercury, 0-1.8 pg/L.
Introduction
The cold vapor absorbance technique has been utilized analytically for more than 50 years to quantitate mercury. The history of this technique prior to 1976, including acid digestion schemes and reducing agents, has been thoroughly reviewed (1). Modern application of this analytical scheme, whether operated in a batch or automated mode, has been based almost entirely on the work of Lindstedt and Skare (2), Hatch and Ott (3) , and Stainton (4) . It is significant to note that the rudimentary acid digestion-reduction procedures of these investigators are still in general use today. Virtually every conceivable combination of strong acid and oxidation agent has been investigated in an attempt to improve the basic method consisting of a sample pretreatment with an admixture of nitric and sulfuric acids followed by either a solid or an aqueous solution of potassium permanganate. In every case, the reducing agent used to liberate elemental mercury is either stannous chloride or stannous sulfate. The focus of early investigations appears to be on total mercury analysis, with little regard to the chemical form of mercury in the original sample.
In recent years, the emphasis in mercury analyses has shifted from total mercury toward the analysis of samples for organically bound mercury because of an increased awareness of the central nervous system effects of these compounds as environmental and occupational toxins (5) and toward inorganic or elemental mercury because of its effects on kidney and liver (5) . Alkylmercury consumed in food is lipid soluble, accumulates in nerve tissue, and is excreted more slowly than inorganic mercury (5) . The analytical emphasis has also shifted from urine to blood because of the long residence time of alkylmercury in blood and the almost complete absorption of the organomercury compounds (5) . The extreme toxicity of alkylmercury has prompted a resurgence of interest in the possibility of biotransformation of elemental or inorganic mercury to alkylmercury compounds in vivo (6) ; the bioconversion of inorganic mercury released from dental amalgams has been of particular interest. It is our opinion that a simple analysis of blood or urine for total mercury is no longer adequate for the assessment of mercury exposure. Blood and urine should be analyzed for both inorganic and alkylmercury.
A review of the literature describing mercury analysis suggests that a simple strong acid-permanganate digestion is not adequate to totally oxidize alkylmercury compounds (7) (8) (9) . When this digestion scheme was applied to samples containing methyl or ethyl mercury, complete recovery was never attained no matter what the concentration of potassium permanganate (7, 8) . This classic digestion method appears to give adequate results only for inorganic mercury (7) . In this paper, we show that this nonreactivity of alkylmercury compounds can be used as an advantage for the differential determination of inorganically and organically bound mercury in blood and urine. Specifically, we apply the classic cold digestion technique followed by automated flow injection cold vapor reduction for the determination of inorganic mercury alone.
For the determination of total mercury in an acidic environment, the only successful methods of sample preparation involve either the complete matrix digestion with mixed nitricperchloric acids (10) or sulfuric acid plus a persulfate salt (8, 9, (11) (12) (13) . Either method provides complete recovery of total mercury regardless of the chemical form. The persulfate method appears attractive because not only does it avoid the hazards of perchloric acid, but persulfate decomposes with heat to form nonreactive sulfate. Excess persulfate does not interfere with the subsequent mercury reduction by stannous chloride. This digestion has been used for total mercury determination in blood (12) , urine (9, 11, 12) , and environmental samples such as water and wastewater (8, 9, 11, 13) .
We acknowledge that other analytical schemes, such as a batch alkaline treatment using different reducing agents to reduce either inorganic or total mercury, have been described (14, 15) . It appears to us that this batch technique, where samples are repeatedly injected into a pool of reducing agent, is not very amenable to automated flow-injection analysis.
Our focus, therefore, has been the judicious application of different acid digestion methods followed by the classic cold vapor analysis in an automated flow injection format. Both blood and urine can be analyzed quickly for inorganic and alkylmercury content once the appropriate acid digestion is applied. To our knowledge, this differential analysis of inorganic and total mercury using different batch acid digestions to liberate the different mercury fractions followed by automated flow injection analysis of the two fractions has been applied only to water and wastewater (8, 13) . In this paper, we show that the differential acid digestion and subsequent automated flow injection cold vapor mercury analysis can be successfully used for the analysis of both inorganic and alkylmercury in both blood and urine.
The development of this differential acid digestion scheme, which facilitates the automated flow injection analysis, was a necessary precursor for the timely assay of inorganic and alkylmercury exposure in a large, unexposed, normal human population. In conjunction with the description of this differential acid digestion-automated flow injection method, we present results for the assay of more than 900 blood and 900 urine samples for both inorganic and organic mercury by this differential acid digestion-cold vapor analysis scheme. The samples were prepared by the two different digestion techniques followed by the automated flow injection cold vapor analysis of mercury. Data on the natural distribution of the inorganic and organic mercury concentration in blood and urine of this normal population are presented.
Materials and Methods

Instrumentation
The flow injection cold vapor mercury analysis system (Perkin-Elmer Corp., Norwalk, CT) consisted of the following components: a model 3100 spectrophotometer equipped with a 19-cm flow cell maintained at 100~ an FIAS 200 pump system with a 1-mL sample loop, an AS 90 autosampler, and an EDL System 2 lamp power supply. The system was controlled
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Materials
Reagents. The following concentrated acids and solid chemicals were purchased from Mallinckrodt Specialty Chemicals (Paris, KY): hydrochloric acid (HCI), AR select, lot 5587 KLGE; sulfuric acid (H2SO4) , AR select, lot 5557 KJSB; stannous chloride dihydrate (SnCI2o2H20) AR, lot 8176 KLDC; potassium permanganate (KMnO4) AR, lot 7068 KATJ; potassium dichromate (K2Cr207), primary standard analytical reagent.
The following reagents were purchased from J.T. Baker Chemical Co. (Phillipsburg, N J): nitric acid (HNO3), Baker Instra-Analyzed Reagent, lot 620044; potassium persulfate (K2S208), Baker Analyzed Reagent, lot E10701; and stock mercury standard, Baker Analyzed Atomic Spectral Standard, lot B09659, nominal concentration 1000 parts-per-million.
Silicone antifoaming agent, lot 146K16537143, was purchased from EM Science (Gibbstown, N J). Methyl mercury chloride, lot F10F, was purchased from Johnson Matthey Electronics (Ward Hill, MA).
Potassium dichromate diluent. K2Cr207 (0.5 g) was diluted to 1000 mL with deionized water, and the solution was stored in an acid-leached plastic bottle.
Potassium permanganate (5%). KMnO 4 (25 g ) was dissolved in 500 mL deionized water, and the solution was stored in an amber bottle at room temperature.
Dilute HCI (5%). Concentrated HC1 (50 mL) was added to a liter volumetric flask and brought to volume with deionized water. The solution was mixed thoroughly.
Dilute HCI (3%) carrier solution. Concentrated HCI (240 mL) and 5 mL silicone antifoam agent were added to an 8-L carboy. The solution was diluted to 8 L with deionized water and then mixed thoroughly.
Stannous chloride (5%). Fresh stannous chloride (50 g) was dissolved in 5% HCI, then diluted to 1 L with 5% HCI, and mixed thoroughly.
Inorganic acid digest mix. To a 2-L Pyrex TM reagent bottle, 1500 mL deionized water was added. Concentrated nitric acid (250 mL) and concentrated sulfuric acid (250 mL) were slowly added as cold water ran over the outside of the Pyrex bottle. The solution was mixed thoroughly.
Working stock mercury standard (1 pg Hg/mL). The stock mercury standard (1.0 mL) was pipetted into an acid-leached plastic 1000-mL volumetric flask and diluted to volume with 0.05% aqueous solution of potassium dichromate.
Working mercury standard (10 ng Hg/mL). The working stock standard (1.0 mL) was pipetted into an acid-leached plastic 100-mL volumetric flask and diluted to volume with 0.05% aqueous potassium dichromate.
Controls. The urine control was a Fisher urine chemistry control, lot N0980156. This control was diluted 1:10 with 0.05% K2Cr207. The blood control was Seronorm whole blood level III, lot 010012 (Nycomed Pharma AS, Oslo, Norway). It was reconstituted with deionized water. Quality-control blood and urine specimens were supplied by the Centre de Toxicologie du Quebec (Quebec, Canada) for our participation in their interlaboratory comparison program. Blood samples were known to contain both inorganic and organic mercury.
Laboratory ware. All plastic containers in which dilute acids were stored were subjected first to acid leaching with dilute nitric acid followed by rinsing with deionized water. Plastic containers for the storage of stannous chloride were cleaned with dilute acid followed by stannous chloride in dilute HCl. Pyrex digestion tubes (125-x 16-mm Pyrex culture tubes, no. 225-367) were purchased from Curtin Matheson Scientific, Inc. (Houston, TX). Nalgene brand polypropylene volumetric flasks were also obtained from Curtin Matheson Scientific.
Blood collection. Samples were collected from a population of generally healthy males and females ranging in age from 25 to 60 years, who had no known exposure to mercury except from the regular diet, the usual number of dental amalgams, and the home and workplace (no direct mercury exposure). All blood samples were collected using the standard phlebotomy technique in Monoject trace element free tubes containing ethylenediaminetetraacetic acid (EDTA; disodium form) anticoagulant (Sherwood Medical Co., St. Louis, MO).
After cleansing with alcohol, blood was collected from an antecubital vein. Blood was mixed thoroughly with the EDTA by inversion of the tube several times. After the samples were received in the metals laboratory, they were again inverted right before sampling to thoroughly mix the plasma with the packed cells.
Urine collection. All urine samples were collected from the same population in acid-leached plastic containers. First void random urine specimens were shipped to the metals laboratory in acid-leached plastic bottles. Aliquots were taken directly from the containers for analysis.
Digestion facility. A Techne DryBlock DB3A (Scientific Products Division, Baxter Diagnostics, McGaw Park, IL) with the original aluminum heating block replaced with a Teflon TM block drilled to accept the digestion tubes was used to digest samples for total mercury analysis. Block temperature was maintained at 95~ The digestion time was approximately 30 rain.
Analytical procedures
Inorganic mercury digestion. Blanks, controls, and biological samples were prepared as follows: The acid digestion mix H2SO 4 in deionized water) was combined with 2 mL 5% KMnO4 and mixed thoroughly. An aliquot of 0.5 mL of blood was added to the mixture. The tube was then vortex mixed every 15 min for 60 min at room temperature. The precipitate was centrifuged at 3000 rpm for 10 min. The supernatant was poured into a clean digestion tube and placed in an autosampler holder. Standards were prepared by pipetting 0.05, 0.10, 0.20, 0.50, 1.0, and 2.5 mL ofa 10-ng Hg/mL standard into separate digestion tubes with KMnO4 solution and acid digest mix. The acid digest mix volume was adjusted by addition of water so that the total volume was 9.0 mL. Because no blood matrix was present, centrifugation was not necessary. These standards contained 0.0, 0.5, 1.0, 2.0, 5.0, 10.0, and 25.0 ng Hg in the 9.0-mL final volume. For urine, a sample size of 1.0 mL was used, reducing the final amount of water added by 0.5 mL.
Total mercury digestion. To every digestion tube, 0.2 g K2S2Os, 4 mL concentrated HNO3, and 0.5 mL H2SO 4 were added, and the solution was thoroughly mixed. Blanks, controls, and blood samples were prepared by pipetting 0.5 mL water, control, or sample into a digestion tube containing the oxidative mixture. Standards were prepared by pipetting 0.0, 0.05, 0.10, 0.20, 0.50, 1.0, and 2.5 mL of the 10-ng Hg/mL standard into separate digestion tubes containing the oxidative mixture. In addition, 0.5 mL whole blood was added to each standard tube as a matrix. For urine, a sample size of 1.0 mL was used. Standards, blanks, controls, and blood and urine specimens were placed in the dry block heater for 30 min. Digestion was considered complete when foaming stopped, and fumes containing oxides of nitrogen appeared above the digestion mixture. Allowing the digestion to proceed longer than 30 min was not detrimental to the final result.
Flow injection analysis. A standard Perkin-Elmer flow in-
jection cold vapor mercury analysis system was used for all analyses. Nominal values for gas and liquid flow rates, carrier and reductant concentrations, spectrophotometer settings, and signal read times are listed in Table I . For each of the analyses, inorganic and total mercury, the digested blanks, standards, controls, and samples were loaded in turn into the AS-90 autosampter. The analysis was completely automated with duplicate readings, and the average reading was printed out. The AS-90 sample probe wash solution was 3% HCI.
Results and Discussion
Total mercury
It has been stated that the successful determination of mercury is dependent on the choice of digestion procedure, which will eliminate volatility loss (1). It should be added that the digestion must transform the mercury species into inorganic mercury--the reducible form.
When blood or urine contains alkylmercury, the classical sample preparation methods of Hatch and Ott (3) and Stainton (4) do not produce mercury in a readily reducible form. In other words, alkylmercury is not quantitated. It has been shown that stronger oxidants, such as V2Os, K2Cr2OT, K2S2Os, or perchloric acid, and higher temperatures of digestion are necessary to break the alkylmercury bond and liberate ionic mercury (8,9-13), which is necessary for the cold vapor atomic absorption technique.
Virtually ideal digestion conditions for the mineralization of all forms of organomercury have been attained by using potassium persulfate in strong acid at moderately elevated temperatures for the digestion medium (9, (11) (12) (13) . This digestion scheme has been applied primarily to water and wastewater (8, 9, 11, 13) , but it has also been applied to urine (9, 11, 12) and blood (12) . It should be noted that for blood, the strong acid digestion contained both KMnO4 and K2S208 but not K2S2Os alone (12) . The clear advantage of a strong acid digest with K2S208 along is described below. As stated in the Introduction, the potential advantage of the strong acid-persulfate digestion is that alkylmercury can be effectively decomposed and that the oxidative power of persulfate is self-diminished as the oxidation proceeds. Unlike the other oxidative additives, such as potassium permanganate, no flocculent precipitate remains after oxidation, and subsequent reduction of ionic mercury is not hindered by excess oxidant in the digest mixture. Thus, the digest is directly applicable to automated flow injection cold vapor atomic absorption spectrophotometry (8, 9, 13) . To our knowledge, the acid persulfate digestion and subsequent automated flow injection analysis of blood has not been reported. Several experiments must be performed, however, to assure that no volatility losses occur and that the digestion provides total mercury recovery irrespective of the form.
Because the digest uses open glass tubes heated to 95~ fears that this process would volatilize mercury must be considered. To allay these fears, blood samples were prepared to contain 5 ng Hg as methyl mercury and subsequently digested for 10-55 rain. Recovery of added mercury versus the digest times measured sequentially over a period of 2 h indicated no loss of mercury.
Stability and recovery of both methyl mercury and inorganic mercury were checked by preparing blood pools with individual compounds added. These pools, consisting of inorganic mercury at 10 and 20 ng/mL and methyl mercury at 5, 10, and 20 ng/mL, were sampled, digested, and analyzed daily for 6 weeks. Recoveries and between-run statistics are shown in Table II . It can be seen that complete recovery of mercury was attained regardless of the chemical form. The day-to-day coefficient of variation was approximately 20% in all cases.
To further substantiate that this digestion-analysis scheme provides quantitation, blood samples from the Quebec Interlaboratory Program were analyzed by both the classical low temperature-permanganate Hatch and Ott (3) method and the proposed persulfate digestion method. Results are shown in Table III . Only the persulfate digestion provided correct quantitation of total mercury. In our execution of the routine strong acid-KMnO4 method of Hatch and Ott (3), blood was added to the acid mix, and then the solution was vortex mixed and centrifuged. Contact time and intimate mixing acceptable of the precipitated protein and the oxidative mixture were limited. It can be seen that range when organomercury was added to blood, 5.0-10.2 the method performed poorly. The Hatch 23.1-37.1
and Ott (3) technique also performed poorly 3.0-7.0 for two of the four blood specimens con-17. 4-28.7 raining inorganic mercury. For urine sam-6.6-12. 6 pies, good recoveries were obtained for 28.1-44.1 inorganic mercury but not for organo-8.6--15.4 mercury. Excellent recoveries were obtained 2.2-5.8
for all urine samples when the persulfate 13.4-22.7 digestion was used.
As a result of our investigation, we have determined the minimum requirements of acid concentration, temperature, and time to adequately digest blood and urine to mineralize alkylmercury and transform inorganic mercury into a readily reducible form for complete quantitation. It can be concluded that a strong acid-K2S208 digest is adequate. No additional oxidants are necessary.
Inorganic mercury
A number of papers, some of which are cited in the Introduction, confirmed that the strong acid-KMnO4 digestion or simple sample acidification are adequate when inorganic mercury is the desired analyte but inadequate when alkylmercury is the desired analyte (7, 8, 13 ). In addition, early studies indicated that the digestion of blood presented major problems for this method, regardless of the desired analyte (1). It has been stated that the analysis of blood was unsuccessful because of the dense precipitate formed when protein was denatured by the strong acid (1). Recent investigators have found the contact time and thorough mixing of the blood with the acid to be critical parameters (6) . Others have determined that the concentration of KMnO4 was critical when plasma and urine were digested (7) . For the preparation of plasma, it was found that the conversion of methyl mercury to the inorganic form was minimized by reducing the KMnO 4 to a minimum concentra- tion (7) . As little as 0.5 mL 6% KMnO4 was needed to liberate all of the inorganic and phenylmercury from plasma (7) .
Our execution of this digestion scheme was specifically tailored to minimize the conversion of methyl mercury to inorganic mercury. For blood, 2 mL 5% KMnO4 was added to the digestion mixture to maintain an oxidizing environment but not convert significant quantities of alkylmercury to inorganic mercury. In addition, the contact (1 h) and vortex (15-min intervals) times assure constant and intimate contact of the denatured protein matrix with the oxidizing acid solution. It should be reiterated that phenylmercury does not behave like alkylmercury but like inorganic mercury (7) . This digestion scheme only excludes alkylmercury compounds but not aryl compounds.
To determine the effectiveness of the procedure, Seronorm trace elements whole blood was analyzed repeatedly for inorganic mercury. This material is certified for both total and inorganic mercury. 
Accuracy
Whole blood samples known to be supplemented with either inorganic or organic mercury from the Quebec Interlaboratory Quality-Control program were analyzed. Selected blood samples received for total mercury analysis were further analyzed for inorganic mercury after the total mercury analyses were completed. The objective of this exercise was to show that the correct concentrations of inorganic and organic mercury could be obtained on totally unknown samples. The results of the inorganic and total mercury analyses were compared with the certificate values and certified ranges in Table IV . The form of mercury supplementation is also listed in this table. Table IV shows that total mercury results achieved by the persulfate oxidation technique are in excellent agreement with the expected results. For the inorganic assay, low mercury concentrations were obtained for the blood supplemented with organic mercury. These were the expected results. Although the exact form of organic mercury added was unknown to us and the endogenous mercury was unknown, low results for inorganic mercury when organic mercury was supplemented were consistent with our expectations. For the blood specimens supplemented with inorganic mercury, our results were within the anticipated ranges for all but one sample. The outlying inorganic mercury result was replicated, and we postulate that the aberrant result was due to an unspecified interference but are unable to suggest what might interfere with this procedure.
Overall, this inorganic-total mercury assay provided correct results for inorganic and organic mercury concentrations on unknown blood samples in which the mercury forms were originally unknown.
Normal study population
More than 900 whole blood and 900 random urine samples were collected from a population of generally healthy humans, who were unexposed to mercury except by the normal amounts of mercury present in the food, air, and soil of a normal environment, and were analyzed for both inorganic and total mercury as part of a mercury study conducted by the National Institute for Dental Research to determine the natural distribution of inorganic and alkylmercury blood concentrations in normal, unexposed adults. Histograms of observed frequency versus mercury concentration found in urine are shown in Figure 1 . Figure 2 depicts the blood results. Total inorganic and organic mercury species frequencies are shown in each figure. For whole blood, the distribution of organomercury and total mercury was strikingly similar. Inorganic mercury concentrations in blood were found to be low. The most frequent result was less than 0.5 IJg Hg/L. From the data, it would appear that the most prevalent form of mercury in the blood of a healthy, unexposed population is alkylmercury.
Inorganic mercury is the predominant species in urine. Organomercury is essentially not present in urine in a normal, unexposed population assayed by the techniques discussed here.
The data presented above is consistent with the narrative presented by Tsalev and Zaprianov (5) . As discussed in their treatise, the main exposure source of mercury is food, mostly in the form of methyl mercury. Distribution of absorbed mercury is as follows: methyl mercury concentrates in red blood cells with a clearance half-life of 70 days, and inorganic mercury concentrates in urine and feces with a half-life of 40 days.
We conclude that our digestion-flow injection analysis scheme, using staged oxidation with either persulfate or permanganate as the oxidant, allows for accurate assessment of the respective concentrations of total and alkylmercury in blood and urine.
